Investigator Initiated Phase 1 Study of TBI-1201

NCT02096614 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: TBI-1201
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

Mie University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]